Maven Sells FIS Chemicals for 4.2x Return

Maven has successfully divested its stake in FIS Chemicals, realizing a substantial 4.2x return on investment for its Maven Investor Partners. This strategic exit underscores the firm's ability to identify and nurture growth in specialized industrial businesses. The transaction, which generated a compelling 33% internal rate of return (IRR), highlights a successful value creation journey since Maven's initial investment in 2020.

The acquisition of FIS Chemicals by Shrieve Chemical, a prominent US-based distributor of specialty and commodity chemicals, marks a new chapter for the Aberdeen-based manufacturer. Established in 1980, FIS Chemicals has built a strong reputation in formulating, producing, and distributing chemical solutions across diverse sectors, including oil & gas, renewables, and marine industries. This diversification has been a key driver of its recent success.

Following a Management Buy-In in 2020, led by Kenny Woods and Gordon Davidson, the FIS Chemicals management team embarked on an ambitious growth strategy. This involved expanding into new market segments, increasing international reach, and broadening its product portfolio through both organic development and strategic acquisitions. This proactive approach resulted in an impressive revenue increase exceeding 160% during the holding period.

Beyond financial performance, FIS Chemicals demonstrated a significant commitment to sustainability. The company has actively pursued initiatives to improve energy efficiency and reduce its environmental footprint, notably achieving a 70% reduction in annual CO2 emissions since 2020. This focus aligns with the growing market demand for environmentally responsible chemical manufacturing and positions the company favorably for future growth under new ownership.

Kenny Woods, CEO of FIS Chemicals, expressed gratitude for Maven's support, stating, "Their expert guidance, continued support and trusted partnership have been invaluable throughout this journey." He further lauded the team's dedication, which fueled the company's impressive year-on-year expansion. The successful integration and growth trajectory of FIS Chemicals are a testament to the collaborative efforts between management and its financial partner.

Martin McLaren, Partner at Maven, commented on the successful outcome, noting the firm's long-standing admiration for FIS Chemicals' market-leading products and stringent quality standards. "The management team have performed exceptionally well in driving its expansion and we have every confidence the company will continue its exciting growth journey with its new US parent," he added. This exit reinforces Maven's investment thesis and its disciplined approach to generating significant returns for its investors.